This individual will be a member of the local quality team that supports preclinical and clinical gene therapy research functions. The candidate will have a clear understanding of the data capture process and will perform QC review of gene therapy research data under direct supervision. The candidate will assist with tracking, trending, and reporting results. The candidate will assist with compiling, analyzing, and trending QC metrics and issues, and communicating to staff as necessary. Primary Responsibilities Include: Performing QC review of data, worksheets, and records from R&D, GCLP, and GLP activities Ensuring data integrity by reviewing forms for correctness and completeness, and managing corrections Assisting with compiling data and QC metrics for internal reporting Assisting with identifying and mitigating gaps in procedures and practices Assisting with management of Facility Records Travel up to 10% Desired Education and Skills: B.A./B.S. degree in Biology, Molecular Biology, Chemistry, or related field and 0-2 years related experience or, A.A./A.S. degree in related field and 2-3 years related experience is required Strong writing and spreadsheet skills are preferable Ability to take direction from other members of the QC Team Ability to multi-task and adapt quickly to a changing environment #LI-Onsite This position requires work on site at one of Sarepta’s facilities in the United States. The targeted salary range for this position is $57,200 - $71,500 per year. Sarepta is making a good faith effort to be transparent and accurate around our hiring ranges. The salary offer is commensurate with Sarepta’s compensation philosophy and considers factors including, but not limited to, education, training, experience, external market conditions, criticality of role, and internal equity. Candidates must be authorized to work in the U.S. Sarepta Therapeutics offers a competitive compensation and benefit package. Sarepta Therapeutics is an Equal Opportunity/Affirmative Action employer and participates in e-Verify. Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.